Integrated Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 25-06-2024
- Paid Up Capital ₹ 1.95 M
as on 25-06-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 102.05 M
as on 25-06-2024
- Satisfied Charges ₹ 32.30 M
as on 25-06-2024
- Revenue 124.93%
(FY 2022)
- Profit 60.76%
(FY 2022)
- Ebitda 42.22%
(FY 2022)
- Net Worth 18.60%
(FY 2022)
- Total Assets 16.49%
(FY 2022)
About Integrated Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.95 M.
The company currently has active open charges totaling ₹10.21 Cr. The company has closed loans amounting to ₹3.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Ahuja and Kiran serve as directors at the Company.
- CIN/LLPIN
U24230HP2005PTC028062
- Company No.
028062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Integrated Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Ahuja  | Director | 04-Mar-2005 | Current |
| Kiran | Director | 11-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Integrated Laboratories.
Integrated Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 124.93% increase. The company also saw a substantial improvement in profitability, with a 60.76% increase in profit. The company's net worth Soared by an impressive increase of 18.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integrated Laboratories?
Unlock access to Integrated Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 29 May 2023 | ₹5.00 M | Open |
Others Creation Date: 19 Dec 2022 | ₹8.90 M | Open |
Others Creation Date: 20 Jun 2020 | ₹8.60 M | Open |
How Many Employees Work at Integrated Laboratories?
Unlock and access historical data on people associated with Integrated Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrated Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrated Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
